Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus

Autor: ALAN LIST, Jp, Greer, Jp, Cousar, Dh, Johnson, Fa, Greco, Dj, Volsky, Dt, Purtilo

Publikováno v: Europe PubMed Central

Epstein-Barr virus has been implicated in the pathogenesis of primary brain lymphoma in patients with congenital or acquired immunodeficiency states. To examine its role in central nervous system (CNS) lymphoma in the immunocompetent host, Epstein-Ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9c7509dbb35c2b2e117358e71435eed7
http://europepmc.org/abstract/med/2172960

Walk the block: Cardiac arrest readiness for basic life support providers.

Autor: Greer JP; Julie Petitta Greer is the clinical nurse manager of the neuroscience medical surgical unit at Clements University Hospital in Dallas, Tex. Also in Dallas, Hend Nadim is a regulatory analyst and member of the Institutional Review Board in the human research protection program and Liz Gunter is a clinical nurse educator at the University of Texas Southwestern Medical Center., Nadim H, Gunter L

Publikováno v: Nursing [Nursing] 2021 Feb 01; Vol. 51 (2), pp. 66-69.

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis.

Autor: Li X; Vanderbilt University, Nashville, TN, USA., Sigworth EA; Vanderbilt University, Nashville, TN, USA., Wu AH; Mount Holyoke College, South Hadley, MA, USA., Behrens J; Vanderbilt University, Nashville, TN, USA., Etemad SA; Vanderbilt University, Nashville, TN, USA., Nagpal S; Stanford University, Palo Alto, CA, USA., Go RS; Mayo Clinic, Rochester, MN, USA., Wuichet K; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Chen EJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Rubinstein SM; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Venepalli NK; University of Illinois at Chicago, Chicago, IL, USA., Tillman BF; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Cowan AJ; University of Washington, Seattle, WA, USA., Schoen MW; Saint Louis University, St. Louis, MO, USA., Malty A; Stanford University, Palo Alto, CA, USA., Greer JP; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Fernandes HD; University of North Dakota, Grand Forks, ND, USA., Seifter A; University of Illinois at Chicago, Chicago, IL, USA., Chen Q; Vanderbilt University, Nashville, TN, USA., Chowdhery RA; University of Illinois at Chicago, Chicago, IL, USA., Mohan SR; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Dewdney SB; Rush University, Chicago, IL, USA., Osterman T; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Ambinder EP; Mount Sinai Medical Center, New York, NY, USA., Buchbinder EI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Schwartz C; University of Illinois at Chicago, Chicago, IL, USA., Abraham I; University of Illinois at Chicago, Chicago, IL, USA., Rioth MJ; University of Colorado, Denver, CO, USA., Singh N; University of Illinois at Chicago, Chicago, IL, USA., Sharma S; Sequoia Regional Cancer Center, Visalia, CA, USA., Gibson MK; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Yang PC; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Warner JL; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA. jeremy.warner@vumc.org.

Publikováno v: Scientific reports [Sci Rep] 2020 Oct 16; Vol. 10 (1), pp. 17536. Date of Electronic Publication: 2020 Oct 16.

Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.

Autor: Sethi TK; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Kovach AE; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Grover NS; Division of Hematology-Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA., Huang LC; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Lee LA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Rubinstein SM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Wang Y; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Morgan DS; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Greer JP; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Park SI; Levine Cancer Institute, Charlotte, NC, USA., Ann Thompson-Arildsen M; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Yenamandra A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Vnencak-Jones CL; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Reddy NM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (12), pp. 2880-2889. Date of Electronic Publication: 2019 Jun 11.

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.

Autor: Park SI; Levine Cancer Institute, Charlotte, North Carolina., Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, New York., Foss FM; Yale University, New Haven, Connecticut., Pinter-Brown LC; University of California Irvine, Irvine, California., Carson KR; Washington University School of Medicine, St. Louis, Missouri., Rosen ST; City of Hope, Duarte, California., Pro B; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois., Hsi ED; Cleveland Clinic, Cleveland, Ohio., Federico M; Centro Oncologico Modenese, Policlinico Modena, Italy., Gisselbrecht C; Saint Louis Hospital, Paris, France., Schwartz M; MS Biostatistics, LLC, Clermont, Florida., Bellm LA; MedNet Solutions, Minnetonka, Minnesota., Acosta M; Spectrum Pharmaceuticals, Inc, Irvine, California., Advani RH; Stanford University Medical Center, Stanford, California., Feldman T; Hackensack University Medical Center, Hackensack, New Jersey., Lechowicz MJ; Emory University, Atlanta, Georgia., Smith SM; University of Chicago, Chicago, Illinois., Lansigan F; Massachusetts General Hospital, Harvard University School of Medicine, Boston, Massachusetts., Tulpule A; University of Southern California, Los Angeles, California., Craig MD; West Virginia University, Morgantown, West Virginia., Greer JP; Vanderbilt University, Nashville, Tennessee., Kahl BS; Washington University School of Medicine, St. Louis, Missouri., Leach JW; Virginia Piper Cancer Institute, Minneapolis, Minnesota., Morganstein N; Overlook Medical Center, Summit, New Jersey., Casulo C; University of Rochester, Rochester, New York., Shustov AR; University of Washington Medical Center, Seattle, Washington.

Publikováno v: Cancer [Cancer] 2019 May 01; Vol. 125 (9), pp. 1507-1517. Date of Electronic Publication: 2019 Jan 29.